Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 24 August 2007:
Vol. 317. no. 5841, pp. 1101 - 1106
DOI: 10.1126/science.317.5841.1101

From the AAAS Office of Publishing and Member Services

BUSINESS OFFICE FEATURE:
Microarray Technologies: Bench to Bedside

Emma Hitt

DNA microarray technology has matured to the point where some applications are deemed reliable enough for use in patient care. At the same time, microarrays are evolving to help expand the understanding of transcriptome complexity: single nucleotide polymorphisms, copy number variation, CpG methylations, microRNAs–so many genetic and epigenetic variations and a slew of microarrays to investigate each one. Furthermore, newer DNA sequencing technologies now threaten to do to microarray technology what automobiles did to the horse and buggy. For now, however, the two approaches appear to coexist happily, and microarrays remain a perfectly reasonable way to get around the genome.





ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)